HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pilot Study of Didanosine in Patients with HIV Dementia.

Abstract
In a pilot open-labeled study 10 subjects with AIDS dementia complex (ADC) were treated with didanosine. Only half of the subjects were able to complete the trial as a result of side effects. Five subjects exhibited improved performance on neuropsychological testing, but the mean change in performance in this small group was not statistically significant. The study suggests that this drug may have some value in ADC patients unable to tolerate other therapies, but that further study is needed to establish this firmly.
AuthorsK D Kieburtz, R W Price, J J Sidtis, C Hall, M Grundman, C McLaren
JournalJournal of neuro-AIDS (J NeuroAIDS) Vol. 1 Issue 4 Pg. 1-5 ( 1996) ISSN: 1069-7438 [Print] United States
PMID16873174 (Publication Type: Journal Article)
Chemical References
  • Didanosine
Topics
  • AIDS Dementia Complex (chemically induced)
  • Didanosine
  • Humans
  • Neuropsychological Tests
  • Pilot Projects

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: